Details of the Drug

General Information of Drug (ID: DM0AOID)

Drug Name
MB-CART19.1
Indication
Disease Entry ICD 11 Status REF
Precursor B-lymphoblastic neoplasm 2A70 Phase 2 [1]
Drug Type
CAR T Cell Therapy
Cross-matching ID
TTD ID
D0F1HT

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
B-lymphocyte surface antigen B4 (CD19) TTW640A CD19_HUMAN CAR-T-Cell-Therapy [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Precursor B-lymphoblastic neoplasm
ICD Disease Classification 2A70
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
B-lymphocyte surface antigen B4 (CD19) DTT CD19 2.33E-24 -1.06 -1.33
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03321123) MB-CART19.1 in Patients With R/R ALL